World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. World Health Organization Website. Available at https://www.who.int/publications/i/item/WHO-HIV-2016.06. Accessed 15 July 2023.

American Association for the Study of Liver Diseases. Call-to-Action to Advance Progress Towards Viral Hepatitis Elimination: A Focus on Simplified Approaches to HCV Testing and Cure. Available at. https://www.aasld.org/aasld-hepatitis-elimination-efforts-0 Accessed 15 July 2023.

U.S. Department of Health and Human Services. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021–2025). Available at https://www.hhs.gov/hepatitis/viral-hepatitis-national-strategic-plan/national-viral-hepatitis-action-plan-overview/index.html. Accessed 15 July 2023.

World Health Organization. Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection. World Health Organization Website. Published June 24, 2022. Available at https://www.who.int/publications/i/item/9789240052697. Accessed 15 July 2023.

Deming P, Martin MT, Chan J, et al. Therapeutic advances in HCV genotype 1 infection: insights from the society of infectious diseases pharmacists. Pharmacotherapy. 2016;36(2):203–17. https://doi.org/10.1002/phar.1700.

Article  PubMed  Google Scholar 

Sebhatu P, Martin MT. Genotype 1 hepatitis C virus and the pharmacist’s role in treatment. Am J Health Syst Pharm. 2016;73(11):764–74. https://doi.org/10.2146/ajhp150704.

Article  CAS  PubMed  Google Scholar 

Mohammad RA, Bulloch MN, Chan J, et al. Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2014;34(12):1341–54. https://doi.org/10.1002/phar.1512.

Article  PubMed  Google Scholar 

Martin MT, Novak J, Hietpas A, et al. A national survey of pharmacist involvement in hepatitis C virus management in the United States. Hepatology. 2022;76(S1):547–8. https://doi.org/10.1002/hep.32697.

Article  Google Scholar 

Freeland C, Ventricelli DJ. The role of the pharmacist in preventing hepatitis B in the context of the opioid crisis. Prev Chronic Dis. 2020;17:E88. https://doi.org/10.5888/pcd17.200062.

Article  PubMed  PubMed Central  Google Scholar 

Meyerson BE, Agley JD, Jayawardene W, et al. Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C. Res Social Adm Pharm. 2020;16(5):699–709. https://doi.org/10.1016/j.sapharm.2019.08.026.

Article  CAS  PubMed  Google Scholar 

Radley A, de Bruin M, Inglis SK, et al. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial. Lancet Gastroenterol Hepatol. 2020;5(9):809–18. https://doi.org/10.1016/S2468-1253(20)30120-5.

Article  PubMed  Google Scholar 

Austin EJ, Gojic AJ, Bhatraju EP, et al. Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs. Int J Drug Policy. 2023;111:103924. https://doi.org/10.1016/j.drugpo.2022.103924.

Article  PubMed  Google Scholar 

Koren DE, Zuckerman A, Teply R, et al. Expanding hepatitis C virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis. 2019;6(7):ofz316.

Article  PubMed  PubMed Central  Google Scholar 

Mikolas LA, Jacques K, Huq M, et al. Utilizing clinical pharmacist specialist to manage hepatitis C virus patients on direct-acting antiviral therapy. J Pharm Pract. 2019;32(6):655–63. https://doi.org/10.1177/0897190018777345.

Article  PubMed  Google Scholar 

Yang S, Britt RB, Hashem MG, et al. Outcomes of pharmacy-led hepatitis C direct-acting antiviral utilization management at a Veterans Affairs medical center. J Manag Care Spec Pharm. 2017;23:364–9.

PubMed  Google Scholar 

Belperio PS, Chartier M, Gonzalez RI, et al. Hepatitis C care in the department of veterans affairs: building a foundation for success. Infect Dis Clin North Am. 2018;32(2):281–92.

Article  PubMed  Google Scholar 

Downes JM, Donovan A, McAdam-Marx C. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center. J Am Pharm Assoc. 2022;62(5):1596–605. https://doi.org/10.1016/j.japh.2022.04.014.

Article  Google Scholar 

Fitzgerald LS, Johnston BE, Patel B, et al. Improving access to hepatitis C treatment using clinical pharmacist services in an uninsured, at-risk population at a community health center. J Health Care Poor Underserved. 2021;32(3):1433–43. https://doi.org/10.1353/hpu.2021.0142.

Article  PubMed  Google Scholar 

Hunt BR, Cetrone H, Sam S, et al. Outcomes of a pharmacist-led hepatitis C virus treatment program in an urban safety-net health system, Chicago, 2017–2019. Public Health Rep. 2022;137(4):702–10. https://doi.org/10.1177/00333549211015664.

Article  PubMed  Google Scholar 

Isho NY, Kachlic MD, Marcelo JC, et al. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center. J Am Pharm Assoc. 2017;57(3S):S259–64. https://doi.org/10.1016/j.japh.2017.03.006.

Article  Google Scholar 

Dong BJ, Lopez M, Cocohoba J. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: a pilot project. J Am Pharm Assoc. 2017;57(4):510-15.e2. https://doi.org/10.1016/j.japh.2017.04.463.

Article  Google Scholar 

Jungnickel PW, Kissack JC, DeSimone EM, et al. Report of the AACP Special Committee on Substance Abuse and Pharmacy Education. AACP.org. Available at https://www.aacp.org/sites/default/files/Report%20of%20the%20AACP%20Special%20Committee%20on%20Substance%20Abuse%20and%20Pharmacy%20Education.pdf. Accessed 15 July 2023.

ACPE. Accreditation Council for Pharmacy Education: Appendix 1. Published February 2, 2015. Available at https://www.acpe-accredit.org/pdf/Standards2016FINAL.pdf. Accessed 15 July 2023.

Thomas K, Muzyk AJ. Surveys of substance use disorders education in US pharmacy programs. Ment Health Clin. 2018;8(1):14–7. https://doi.org/10.9740/mhc.2018.01.014.

Article  PubMed  PubMed Central  Google Scholar 

Dutta AP, Daftary MN, Oke F, et al. Geriatric education in US schools of pharmacy: a snapshot. Consult Pharm. 2005;20(1):45–52. https://doi.org/10.4140/tcp.n.2005.45.

Article  PubMed  Google Scholar 

Phillips JA, Gabay MP, Ficzere C, et al. Curriculum and instructional methods for drug information, literature evaluation, and biostatistics: survey of US pharmacy schools. Ann Pharmacother. 2012;46(6):793–801. https://doi.org/10.1345/aph.1Q813.

Article  PubMed  Google Scholar 

Rathbun RC, Durham SH, Farmer KC, et al. Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States. Curr Pharm Teach Learn. 2020;12(8):910–7. https://doi.org/10.1016/j.cptl.2020.04.007.

Article  PubMed  Google Scholar 

Kibicho J, Pinkerton SD, Owczarzak J. Community-based pharmacists’ needs for HIV-related training and experience. J Pharm Pract. 2014;27(4):369–78. https://doi.org/10.1177/0897190013513301.

Article  PubMed  Google Scholar 

AACP - American Association of Colleges of Pharmacy. AACP Institutional Membership. Available at https://www.aacp.org/article/aacp-institutional-membership. Accessed 15 July 2023.

U.S. Department of Commerce: Economics and Statistics Administration. Geographic Levels. United States Census Bureau. Updated 8 Oct 2021. Available at Available at https://www.census.gov/programs-surveys/economic-census/guidance-geographies/levels.html#par_textimage_34. Accessed 15 July 2023.

Centers for Disease Control and Prevention. Viral Hepatitis Surveillance Report—United States, 2020. Published September 2022. Available at https://www.cdc.gov/hepatitis/statistics/2020surveillance/index.htm. Accessed 15 July 2023.

Dreischulte T, van den Bemt B, Steurbaut S. European society of clinical pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper. Int J Clin Pharm. 2022;44:837–42. https://doi.org/10.1007/s11096-022-01422-7.

Article  PubMed  PubMed Central  Google Scholar 

Moura L, Steurbaut S, Salvesen Blix H, et al. A cross-sectional survey to map clinical pharmacy education and practice in europe. Int J Clin Pharm. 2022;44(1):118–26. https://doi.org/10.1007/s11096-021-01321-3.

Article  PubMed  Google Scholar 

American College of Clinical Pharmacy, Schwinghammer TL, Crannage AJ, Boyce EG, et al. ACCP pharmacotherapy didactic curriculum toolkit; 2016. Available at https://www.accp.com/docs/positions/misc/Toolkit_final.pdf. Accessed 15 July 2023.

Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192-1207.

Article  PubMed  PubMed Central  Google Scholar 

Ahmad FB, Cisewski JA, Rossen LM, et al. Provisional drug overdose death counts. National Center for Health Statistics. 2023. Available at https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation. Accessed 27 June 2023.

Safdar N, Abbo LM, Knobloch MJ, et al. Research methods in healthcare epidemiology: survey and qualitative research. Infect Control Hosp Epidemiol. 2016;37(11):1272–7. https://doi.org/10.1017/ice.2016.171.

Article  PubMed  PubMed Central  Google Scholar